Evidence map›Paper›PMID 41244906›Full record

ArticleFrontiers in oncology2025

Intraductal papilloma of breast with carcinoma

Lu Zhao, Li Wu, Shuai Luo, Yao Li, Jinjing Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lu ZhaoDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Li WuDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Shuai LuoDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Yao LiDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Jinjing WangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The simultaneous occurrence of intraductal papilloma and malignant breast lesions is rare, as is the presence of ductal carcinoma Case presentation: A 49-year-old female with a decade-long history of pulmonary tuberculosis presented with a right breast mass, first noticed 10 days prior. Color Doppler ultrasound identified a hypoechoic nodule in the right breast, and breast MRI, both with and without contrast, revealed multiple regions of abnormal enhancement in the right breast, along with enlarged axillary lymph nodes. Tissue biopsy confirmed intraductal papilloma with malignant transformation in some areas (low-grade DCIS). Axillary lymph node biopsy was positive for tuberculosis. The patient underwent right mastectomy, and follow-up after one month showed no recurrence. Conclusion: Tuberculosis remains prevalent in developing countries, and this patient's history of pulmonary tuberculosis spans over 10 years. The co-occurrence of breast cancer and axillary tuberculous lymphadenitis is unusual. A prompt and accurate diagnosis of breast cancer is vital, involving preoperative imaging, biopsy, and pathological assessment during and after surgery. Once diagnosed, a treatment plan tailored to the characteristics of carcinoma

Indexed as

breastductal carcinoma in situintraductal papillomapathologytreatmenttuberculous lymphadenitis

Identifiers

PMID41244906
PMCPMC12614461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.